Try our Advanced Search for more refined results

March 02, 2007

OTSUKA PHARMACEUTICAL CO., LTD. v. SANDOZ, INC.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 15, 2015

    Otsuka Loses Fee Bid In Abilify Patent Suit

    A New Jersey federal judge has refused to order several generic drug companies to pay Otsuka Pharmaceutical Co.'s attorneys' fees in a case over schizophrenia drug Abilify, despite the Federal Circuit calling their arguments the "poster child" for a flawed patent case.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login